ACEHOUND™ Launches Nationwide, Using AI and Industry Expertise to Streamline Medical Prior Authorization Appeals, Reducing Care Delays & Provider Burden While Improving Patient Access to Needed Therapies

Audio By Carbonatix

AMHERST, N.H.--(BUSINESS WIRE)--Oct 7, 2025--

Today, ACEHOUND™, the first subscription-based HTML platform to harness AI, machine learning, and industry expertise to streamline the creation of high-quality medical necessity, appeals, and exception letters, announces its nationwide U.S. launch. ACEHOUND™ helps providers generate essential coverage documentation in minutes, to help secure patient access to needed therapies.

As much as 50% of all in-network prior authorization requests are denied by Marketplace insurers. i Physicians estimate that prior authorization denials result in care delays 94% of the time, according to the American Medical Association’s annual nationwide physician survey. ii Only approximately 10% of denials are ever appealed even though more than 80% of appealed denials are overturned, according to data submitted by Medicare Advantage insurers submitted to the Centers for Medicare & Medicaid Services (CMS) between 2019 and 2022. Nearly all (99%) Medicare Advantage enrollees participate in plans that require prior authorization for certain services, including drugs, inpatient, and outpatient services. iii

“Provider offices are often overwhelmed by administrative insurance requirements and struggle to hire, maintain, and train staff to appeal denied prior authorization requests. It’s a sad, yet understandable reality that too many well-meaning providers sacrifice time for patient care to meet insurers’ paperwork requirements,” says Eric Mensh, Founder of ACEHOUND™. “ACEHOUND™ enables more efficient appeal submissions by automating the letter-writing task. Our solution combines cutting-edge technology with deep industry experience to facilitate more successful appeals. This helps improve patient outcomes by speeding time from the prescription to treatment and ensures patients will get the treatment that was prescribed.”

Practicing physicians surveyed by the American Medical Association shared that prior authorization programs are time-consuming barriers to the delivery of medically necessary treatment; contribute to physician and staff burnout; reduce employee productivity; and lead to unnecessary costs to patients— trying ineffective treatments due to step therapy requirements, additional office visits, emergency room visits, unanticipated hospital stays, out-of-pocket care expenses, and missed work due to continued illness while waiting for care. iv

“Costly services place a significant burden on many patients. Medical societies are calling for human oversight, transparency and regulatory guardrails for AI in authorization reviews. We flip that concern on its head,” adds Mensh. “Our platform brings the power of technology and human oversight together to help providers get more done faster. With time at an ever-increasing premium for everyone, ACEHOUND™ offers tangible benefits that ultimately improve patient care.”

About ACEHOUND™

ACEHOUND™ is a subscription-based HTML platform that is free to end-users, creates efficiencies in generating high-quality medical necessity, exception, and appeal letters. The ACEHOUND™ platform is built to streamline patient access to needed treatments and speed approvals while easing practice burden. ACEHOUND™ partners with both pharmaceutical companies and providers to achieve these goals.

ACEHOUND™ was developed by industry experts in market access, compliance, and data privacy. And is owned and operated by Access Pointe Managed Markets, LLC, led by Eric Mensh, a leading expert driving key insights and solutions for market access and reimbursement strategies in the pharmaceutical and biotech industries. Mensh has always put patients first, which was the guiding principle in the creation of ACEHOUND. The ACEHOUND™ platform is fully integrated with EPIC and other EMRs to offer seamless connectivity. ACEHOUND™ is Health Insurance Portability and Accountability Act (HIPAA) and SOC 2 compliant. ACEHOUND™ helps patients access the medications their health care professional prescribed.

i KFF. https://www.kff.org/private-insurance/issue-brief/claims-denials-and-appeals-in-aca-marketplace-plans-in- 2023/. Published Jan 27. 2025. Accessed 9/22/2025.

ii American Medical Association. AMA survey indicates prior authorization wreaks havoc on patient care. AMA Press Releases. https://www.ama-assn.org/press-center/ama-press-releases/ama-survey-indicates-prior-authorization- wreaks-havoc-patient-care. Published Sept 14, 2025. Accessed September 23, 2025.

iii KFF. Medicare Advantage in 2024: Premiums, Out-of-Pocket Limits, Supplemental Benefits, and Prior Authorization. Aug 8. 2024. https://www.kff.org/medicare/medicare-advantage-in-2024-premiums-out-of-pocket- limits-supplemental-benefits-and-prior-authorization/. Accessed 9/22/2025.

iv American Medical Association.2024 prior authorization physician survey. AMA prior authorization (PA) physician survey | AMA. Accessed 9/22/2-25.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251007508376/en/

CONTACT: For more information, contact:

Kelly Laban,[email protected]

KEYWORD: UNITED STATES NORTH AMERICA NEW HAMPSHIRE

INDUSTRY KEYWORD: BIOTECHNOLOGY PRACTICE MANAGEMENT PHARMACEUTICAL GENERAL HEALTH HEALTH ARTIFICIAL INTELLIGENCE TECHNOLOGY OTHER HEALTH

SOURCE: ACEHOUND

Copyright Business Wire 2025.

PUB: 10/07/2025 08:00 AM/DISC: 10/07/2025 07:59 AM

http://www.businesswire.com/news/home/20251007508376/en